COPY (LIONSGATE)
poster44ny Member Level
COPY (LIONSGATE)
poster44ny Member Level Monday, 07/19/21 03:22:00 PM
Re: None 0
Post #
MAJOR-NEWS: LIONSGATE.has.a.JV.(joint-Venture).on.WILDFIRE.(the-movie).with.HHSE. This was accidentally-revealed at Cannes by MARIAH DAVIS, one of the actresses on the film, but her tweet was later deleted due to LIONSGATE wanting to be THE ONE to announce it first.
HHSE
Hannover House Inc. (HHSE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Atomic Orbit Unlocks Global Connectivity Think about the hassle businesses face globally when devices drop off the grid. It's like losing a lifeline. Atomic Mobile, outta Spring Lake, decided enough's enough and dropped their latest brainchild on the world — Atomic Orbit. This bad boy is turning heads because it's not clinging to a single carrier. Instead, it's dancing...
Continue Reading
JDEnergy: A Persistent Force in Energy Storage Let's get straight to the point: JDEnergy is hitting the mark once again. For the seventh consecutive time, they've nailed a spot on BloombergNEF's Tier 1 Energy Storage Manufacturer list. Now, this ain't no small feat, folks. It’s like being a heavyweight champ keeping the title even as the competition intensifies and the...
Continue Reading
Strategic Expansion: LUX Infusion's Bold Move When it comes to healthcare, it's often about pulling the right strings at the right time, and today, LUX Infusion's got their timing spot on. They've swooped in with a savvy acquisition, taking over two key specialty infusion centers in Lincoln and Omaha. This isn't just a pencil-pusher's cynical corporate move; it's a push...
Continue Reading
Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...
Continue Reading
Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...
Continue Reading
A Sneak Peek into Yuhang's Technological Leap Imagine strolling through a place where technology and nature coexist in harmony. That's exactly what journalists from around the globe got to experience during their recent jaunt to Yuhang District in Hangzhou. We're talking about reps from South Korea, Turkey, the U.S., and even Cuba getting a firsthand look at Yuhang's...
Continue Reading
Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...
Continue Reading
Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...
Continue Reading
Riding the Electronics Tsunami The consumer electronics sector isn't just catching a wave; it's barreling through a technological tsunami. Projected to leap from USD 1100.87 billion in 2026 to USD 2825.55 billion by 2035, we're talking a whopping 11.04% CAGR. It's driven by none other than the smartphone frenzy, intelligent computing advances, and the almighty connected...
Continue Reading
Making Diabetic Eye Exams Effortless Folks, the healthcare landscape just got a jolt from an unexpected corner. AEYE Health, with its AI wizardry, snagged the 2026 Prix Galien USA Award. This ain't your run-of-the-mill blue ribbon from a county fair; it's a heavyweight title in the world of medical innovation. The harbinger of this change? AEYE-DS, an AI-packed gadget...
Continue Reading
Top 5 Most Recently Viewed Articles
High Wire Networks Reports Impressive Gross Profit Growth High Wire Networks, Inc. (OTCQB: HWNI), known globally as a premier provider of managed cybersecurity services, announced an exciting milestone: a remarkable 10% boost in gross profit during the last 90 days. This significant growth is attributed to a combination of strategic initiatives, operational focus, and a...
Continue Reading
AffableBPM Accepted into Prestigious Creative Destruction Lab Program AffableBPM, a key player in automating back-office processes for healthcare, has proudly announced its acceptance into the renowned Creative Destruction Lab (CDL) program. This exciting development positions the company to join the CDL-Seattle’s Computational Health Stream, a part of the Foster School...
Continue Reading
Analyzing Short Interest Trends in Everest Group Everest Group recently reported an increase in its short percent of float, which has risen to an impressive 28.07%. Currently, there are approximately 799 thousand shares sold short, accounting for 2.92% of the total shares available for trading. Given the current trading volume, it would take traders an average of 1.73...
Continue Reading
Class Action Lawsuit Against Integral Ad Science Holding Corp. Pomerantz LLP has announced the initiation of a class action lawsuit against Integral Ad Science Holding Corp. (NASDAQ: IAS). This legal action arises from various concerns regarding the company’s business practices and potential securities fraud. Investors who believe they may have suffered losses due to...
Continue Reading
Bernstein’s Cautious Outlook on Tesla Bernstein SocGen Group recently reaffirmed its Underperform rating on Tesla (NASDAQ: TSLA) with a price target of $120. The firm analyzed Tesla's third-quarter delivery numbers, reporting approximately 463,000 vehicles delivered. While this figure aligns with sell-side consensus expectations, it fell slightly short of the projected...
Continue Reading